BIRDIE BIOPHARMACEUTICALS, INC

Organization

GRAND CAYMAN, KY

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
2-amino-quinoline derivatives
- Patent number 11,834,448
- Issue date Dec 5, 2023
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for treating HER2 positive tumors
- Patent number 11,786,604
- Issue date Oct 17, 2023
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-EGFR combinations for treating tumors
- Patent number 11,702,476
- Issue date Jul 18, 2023
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for immunotherapy
- Patent number 11,633,495
- Issue date Apr 25, 2023
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for immunotherapy
- Patent number 11,633,494
- Issue date Apr 25, 2023
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions
- Patent number 11,517,567
- Issue date Dec 6, 2022
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PD-L1 combinations for treating tumors
- Patent number 11,279,761
- Issue date Mar 22, 2022
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD20 combinations for treating tumors
- Patent number 11,220,552
- Issue date Jan 11, 2022
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti PD-L1 conjugates for treating tumors
- Patent number 11,130,812
- Issue date Sep 28, 2021
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-amino-quinoline derivatives
- Patent number 11,053,240
- Issue date Jul 6, 2021
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-HER2 combinations for treating tumors
- Patent number 11,046,781
- Issue date Jun 29, 2021
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for immunotherapy
- Patent number 10,780,180
- Issue date Sep 22, 2020
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for immunotherapy
- Patent number 10,744,206
- Issue date Aug 18, 2020
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for targeted immunotherapy
- Patent number 10,660,971
- Issue date May 26, 2020
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for targeted immunotherapy
- Patent number 10,548,988
- Issue date Feb 4, 2020
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for treating EGFR expressing tumors
- Patent number 10,548,985
- Issue date Feb 4, 2020
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for immunotherapy
- Patent number 10,328,158
- Issue date Jun 25, 2019
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for targeted immunotherapy
- Patent number 9,878,052
- Issue date Jan 30, 2018
- BIRDIE BIOPHARMACEUTICALS INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for immunotherapy
- Patent number 9,827,329
- Issue date Nov 28, 2017
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY
- Publication number 20230390410
- Publication date Dec 7, 2023
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER TREATMENT WITH TLR AGONIST
- Publication number 20230346775
- Publication date Nov 2, 2023
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS
- Publication number 20230132111
- Publication date Apr 27, 2023
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD20 COMBINATIONS FOR TREATING TUMORS
- Publication number 20220204641
- Publication date Jun 30, 2022
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE MODULATORY COMPOSITIONS AND METHODS FOR TREATING CANCERS
- Publication number 20220175762
- Publication date Jun 9, 2022
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-EGFR COMBINATIONS FOR TREATING TUMORS
- Publication number 20220089749
- Publication date Mar 24, 2022
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti PD-L1 Conjugates for Treating Tumors
- Publication number 20220033503
- Publication date Feb 3, 2022
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE MODULATORY COMBINATIONS AND METHODS FOR TREATING CANCERS
- Publication number 20220016152
- Publication date Jan 20, 2022
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-HER2 COMBINATIONS FOR TREATING TUMORS
- Publication number 20210363271
- Publication date Nov 25, 2021
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-HER2 COMBINATIONS FOR TREATING TUMORS
- Publication number 20210347911
- Publication date Nov 11, 2021
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS
- Publication number 20210330664
- Publication date Oct 28, 2021
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AMINO-QUINOLINE DERIVATIVES
- Publication number 20210261549
- Publication date Aug 26, 2021
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-AMINO-QUINOLINE DERIVATIVES
- Publication number 20210261548
- Publication date Aug 26, 2021
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOQUINOLINE COMPOUNDS AND USES THEREOF
- Publication number 20210214354
- Publication date Jul 15, 2021
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lihu Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY
- Publication number 20200353093
- Publication date Nov 12, 2020
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY
- Publication number 20200345860
- Publication date Nov 5, 2020
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR TREATING HER2 POSITIVE TUMORS
- Publication number 20200276327
- Publication date Sep 3, 2020
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETED IMMUNOTHERAPY
- Publication number 20200246478
- Publication date Aug 6, 2020
- Birdie Biopharmaceuticals, Inc.
- Lixin Li
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
COMPOUNDS FOR TARGETED IMMUNOTHERAPY
- Publication number 20200179527
- Publication date Jun 11, 2020
- Birdie Biopharmaceuticals, Inc.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AMINO-QUINOLINE DERIVATIVES
- Publication number 20200055851
- Publication date Feb 20, 2020
- Birdie Biopharmaceuticals, Inc.
- Lixin LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY
- Publication number 20190269789
- Publication date Sep 5, 2019
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY
- Publication number 20190269790
- Publication date Sep 5, 2019
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPOSITIONS AND METHODS FOR TREATING CANCERS
- Publication number 20190099415
- Publication date Apr 4, 2019
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS
- Publication number 20190048084
- Publication date Feb 14, 2019
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD20 COMBINATIONS FOR TREATING TUMORS
- Publication number 20190016819
- Publication date Jan 17, 2019
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-HER2 COMBINATIONS FOR TREATING TUMORS
- Publication number 20190002583
- Publication date Jan 3, 2019
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS
- Publication number 20180346572
- Publication date Dec 6, 2018
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETED IMMUNOTHERAPY
- Publication number 20180177888
- Publication date Jun 28, 2018
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TARGETED IMMUNOTHERAPY
- Publication number 20180177887
- Publication date Jun 28, 2018
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds and Compositions for Immunotherapy
- Publication number 20180110874
- Publication date Apr 26, 2018
- BIRDIE BIOPHARMACEUTICALS, INC.
- Lixin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

BIRDIE BIOPHARMACEUTICALS, INC

Organization

Patents Grantslast 30 patents

2-amino-quinoline derivatives

Compounds and compositions for treating HER2 positive tumors

Anti-EGFR combinations for treating tumors

Compounds and compositions for immunotherapy

Compounds and compositions for immunotherapy

Pharmaceutical compositions

Anti-PD-L1 combinations for treating tumors

Anti-CD20 combinations for treating tumors

Anti PD-L1 conjugates for treating tumors

2-amino-quinoline derivatives

Anti-HER2 combinations for treating tumors

Compounds and compositions for immunotherapy

Compounds and compositions for immunotherapy

Compounds for targeted immunotherapy

Compounds for targeted immunotherapy

Compounds and compositions for treating EGFR expressing tumors

Compounds and compositions for immunotherapy

Compounds for targeted immunotherapy

Compounds and compositions for immunotherapy

Patents Applicationslast 30 patents

COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY

CANCER TREATMENT WITH TLR AGONIST

PHARMACEUTICAL COMPOSITIONS

ANTI-CD20 COMBINATIONS FOR TREATING TUMORS

IMMUNE MODULATORY COMPOSITIONS AND METHODS FOR TREATING CANCERS

ANTI-EGFR COMBINATIONS FOR TREATING TUMORS

Anti PD-L1 Conjugates for Treating Tumors

IMMUNE MODULATORY COMBINATIONS AND METHODS FOR TREATING CANCERS

ANTI-HER2 COMBINATIONS FOR TREATING TUMORS

ANTI-HER2 COMBINATIONS FOR TREATING TUMORS

PHARMACEUTICAL COMPOSITIONS

2-AMINO-QUINOLINE DERIVATIVES

2-AMINO-QUINOLINE DERIVATIVES

IMIDAZOQUINOLINE COMPOUNDS AND USES THEREOF

COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY

COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY

COMPOUNDS AND COMPOSITIONS FOR TREATING HER2 POSITIVE TUMORS

COMPOUNDS FOR TARGETED IMMUNOTHERAPY

COMPOUNDS FOR TARGETED IMMUNOTHERAPY

2-AMINO-QUINOLINE DERIVATIVES

COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY

COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY

COMBINATION THERAPY COMPOSITIONS AND METHODS FOR TREATING CANCERS

ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS

ANTI-CD20 COMBINATIONS FOR TREATING TUMORS

ANTI-HER2 COMBINATIONS FOR TREATING TUMORS

ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS

COMPOUNDS FOR TARGETED IMMUNOTHERAPY

COMPOUNDS FOR TARGETED IMMUNOTHERAPY

Compounds and Compositions for Immunotherapy

Trademarklast 30 trademarks